Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Ocular Surface Inflammatory Mediators and Ocular Surface Metrology Effected by Lotemax

NCT02322528 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT02322528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02322528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Ocular Surface Inflammatory Mediators and Ocular Surface Metrology Effected by Lotemax
Lead sponsor
University of Rochester
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2014
Completion date
August 31, 2015
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sjogren's disease